These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12082691)

  • 41. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
    Emens JS; Eastman CI
    Drugs; 2017 Apr; 77(6):637-650. PubMed ID: 28229310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebral modulation of circadian sleep-wake rhythms.
    Jan JE; Ribary U; Wong PK; Reiter RJ; Bax MC; Wasdell MB
    J Clin Neurophysiol; 2011 Apr; 28(2):165-9. PubMed ID: 21399521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A circadian rhythm sleep disorder: melatonin resets the biological clock.
    Abbas A; Raju J; Milles J; Ramachandran S
    J R Coll Physicians Edinb; 2010 Dec; 40(4):311-3. PubMed ID: 21132137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin for the treatment of handicapped children with severe sleep disorders.
    Jan MM
    Pediatr Neurol; 2000 Sep; 23(3):229-32. PubMed ID: 11033285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A practical approach to circadian rhythm sleep disorders.
    Bjorvatn B; Pallesen S
    Sleep Med Rev; 2009 Feb; 13(1):47-60. PubMed ID: 18845459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Sleep disorders in healthy children follows often a "learnt" behavioral pattern. Diurnal rhythm disturbances are dominating among children with functional disabilities].
    Palm L; Hellsten H
    Lakartidningen; 1999 Nov; 96(47):5200-6. PubMed ID: 10608111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Case study: the use of melatonin in a boy with refractory bipolar disorder.
    Robertson JM; Tanguay PE
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):822-5. PubMed ID: 9183138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia.
    van der Heijden KB; Smits MG; van Someren EJ; Boudewijn Gunning W
    J Sleep Res; 2005 Jun; 14(2):187-94. PubMed ID: 15910516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Free-running of plasma melatonin rhythm prior to full manifestation of a non-24 hour sleep-wake syndrome.
    Hashimoto S; Nakamura K; Honma S; Honma K
    Psychiatry Clin Neurosci; 1998 Apr; 52(2):264-5. PubMed ID: 9628187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case study of circadian rhythm sleep disorder following haloperidol treatment: reversal by risperidone and melatonin.
    Ayalon L; Hermesh H; Dagan Y
    Chronobiol Int; 2002 Sep; 19(5):947-59. PubMed ID: 12405556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances.
    Palm L; Blennow G; Wetterberg L
    Dev Med Child Neurol; 1997 May; 39(5):319-25. PubMed ID: 9236698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of melatonin in circadian rhythm disorders and following phase shifts.
    Skene DJ; Deacon S; Arendt J
    Acta Neurobiol Exp (Wars); 1996; 56(1):359-62. PubMed ID: 8787196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Irregular Sleep-Wake Rhythm Disorder.
    Abbott SM; Zee PC
    Sleep Med Clin; 2015 Dec; 10(4):517-22. PubMed ID: 26568126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of timing in melatonin administration in a blind man.
    Tzischinsky O; Pal I; Epstein R; Dagan Y; Lavie P
    J Pineal Res; 1992 Apr; 12(3):105-8. PubMed ID: 1507054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Effect of Blindness on Biological Rhythms and the Consequences of Circadian Rhythm Disorder.
    Atan YS; Subaşı M; Güzel Özdemir P; Batur M
    Turk J Ophthalmol; 2023 Apr; 53(2):111-119. PubMed ID: 37089032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
    Neubauer DN
    Drugs Today (Barc); 2015 Jan; 51(1):29-35. PubMed ID: 25685859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Usefulness of melatonin for developmental sleep and emotional/behavior disorders--studies of melatonin trial on 50 patients with developmental disorders].
    Ishizaki A; Sugama M; Takeuchi N
    No To Hattatsu; 1999 Sep; 31(5):428-37. PubMed ID: 10487068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significant sleep dysregulation in a toddler with developmental delay.
    Stein MT; Owens J; Abbott M
    J Dev Behav Pediatr; 2010 May; 31(4):357-9. PubMed ID: 20453583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Melatonin Treatment in Children with Developmental Disabilities.
    Schwichtenberg AJ; Malow BA
    Sleep Med Clin; 2015 Jun; 10(2):181-7. PubMed ID: 26055866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.